ArticleCureus2025
Challenges in the Diagnosis and Management of Graves' Disease in an Elderly Female With Antithyroid Drug Intolerance.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graves' Disease (GD) is uncommon in the elderly. This report explores the case of an 87-year-old female diagnosed with Graves' Disease following a non-specific decline and new-onset atrial fibrillation (AF). Incidental blood tests on admission revealed severe thyrotoxicosis with a thyroid-stimulating hormone (TSH) level of <0.0005mu/L and free thyroxine (fT4) level of 72 pmol/L, with positive TSH-receptor antibodies confirming Graves' Disease. Initial management with carbimazole achieved some biochemical control but led to hepatotoxicity. Reduced dosing caused similar hepatic derangement. Propylthiouracil also did not adequately control thyroid function and caused mild liver function derangement. The patient re-presented with decompensated thyrotoxicosis, including hypotension, fast AF, and confusion. The endocrinology multidisciplinary team (MDT) decided the patient was unsuitable for definitive treatments; hence, Lugol's iodine was commenced. Thyroid function gradually stabilised on a combination of Lugol's iodine, propranolol, steroid and low-dose propylthiouracil. This case was challenging due to anti-thyroid drug intolerance in conjunction with limited definitive management options, with our endocrinology team resorting to non-standard therapies to stabilise the patient. This case ultimately demonstrates the diagnostic and therapeutic challenges of managing Graves' hyperthyroidism in the elderly. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.